Histopathological characteristics of breast cancer and evaluation of ER alpha and Her-2neu using immunohistochemical and RT-PCR techniquesFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 31 March 2014

References

• S.OmarH.KhaledR.GaafarA.R.ZekryS.EissaO.ElkhatibBreast cancer in Egypt: a review of disease presentation and detection strategiesEast Mediterr Health J932003448463
   Google Scholar
• I.A.El-AttarCancer databases in the Arab WorldEthn Dis151 Suppl 12005 S 1-3-4
   Web of Science ®Google Scholar
• C.U.IhemelanduL.D.LeffallJrR.L.DewittyT.J.NaabH.M.MezghebeK.H.MakambiMolecular breast cancer subtypes in premenopausal and postmenopausal African American women: age-specific prevalence and survivalJ Surg Res14312007109118
   Web of Science ®Google Scholar
• J.K.WienckeImpact of race/ethnicity on molecular pathways in human cancerNat Rev Cancer4120047984
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas NetworkComprehensive molecular portraits of human breast tumoursNature490741820126170
   PubMed Web of Science ®Google Scholar
• T.SørlieC.M.PerouR.TibshiraniT.AasS.GeislerH.JohnsenGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci9820011086910874
   PubMed Web of Science ®Google Scholar
• V.AlmendroG.FusterHeterogeneity of breast cancer: etiology and clinical relevanceClin Transl Oncol13112011767773
   Web of Science ®Google Scholar
• J.RheeS.W.HanD.Y.OhJ.H.KimS.A.ImW.HanThe clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancerBMC Cancer82008307
   PubMed Web of Science ®Google Scholar
• G.MosoyanC.NagiS.MarukianA.TeixeiraA.SimonianMultiple breast cancer cell-lines derived from a single tumor differ in their molecular characteristics and tumorigenic potentialPLoS One812013e55145
   Web of Science ®Google Scholar
• X.LiJ.HuangP.YiR.A.BambaraR.HilfM.MuyanSingle-chain estrogen receptors (ERs) reveal that the ER alpha/beta heterodimer emulates functions of the ER alpha dimer in genomic estrogen signaling pathwaysMol Cell Biol2417200476817694
   PubMed Web of Science ®Google Scholar
• J.R.GosdenP.G.MiddletonD.RoutLocalization of the human oestrogen receptor gene to chromosome 6q24–q27 by in situ hybridizationCytogenet Cell Genet1433–41986218220
   Google Scholar
• N.R.CandelariaK.LiuC.Y.LinEstrogen receptor alpha: Molecular mechanisms and emerging insightsJ Cell Biochem201310.1002/jcb.24584 [Epub ahead of print]
   Web of Science ®Google Scholar
• S.GreenP.WalterV.KumarA.KrustJ.M.BornertP.ArgosHuman oestrogen receptor cDNA: sequence, expression and homology to v-erb-ANature32060581986134139
   PubMed Web of Science ®Google Scholar
• G.L.GreeneP.GilnaM.WaterfieldA.BakerY.HortJ.ShineSequence and expression of human estrogen receptor complementary DNAScience2314742198611501154
   Web of Science ®Google Scholar
• G.G.KuiperJ.A.GustafssonThe novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogensFEBS Lett410119978790
   Web of Science ®Google Scholar
• W.L.McGuireG.C.ChamnessS.A.FuquaEstrogen receptor variants in clinical breast cancerMol Endocrinol511199115711577
   Google Scholar
• I.PoolaJ.AbrahamK.BaldwinIdentification of ten exon deleted ERβ mRNAs in human ovary, breast, uterus and bone tissues: alternate splicing pattern of estrogen receptor ß mRNA is distinct from that of estrogen receptor alphaFEBS Lett5161–32002133138
   Web of Science ®Google Scholar
• L.C.MurphyEstrogen receptor variants in human breast cancerMol Cell Endocrinol7421990 C83-C6
   Web of Science ®Google Scholar
• S.A.FuqaD.C.AllredR.J.AuchusExpression of estrogen receptor variantsJ Cell Biochem Suppl17G1993194197
   Google Scholar
• C.A.EncarnacionS.A.FuquaEstrogen receptor variants in breast cancerCancer Treat Res71199497109
   Google Scholar
• U.PfefferEstrogen receptor mRNA variants. Do they have a physiological role?Ann N Y Acad Sci7841996304313
   Web of Science ®Google Scholar
• Q.-X.ZhangS.G.HilsenbeckS.A.W.FuquaA.BorgMultiple splicing variants of the estrogen receptor are present in individual human breast tumorsJ Steroid Biochem Mol Biol593–41996251260
   Web of Science ®Google Scholar
• L.K.DiazN.SneigeEstrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracyAdv Anat Pathol12120051019
   Web of Science ®Google Scholar
• G.ReidS.DengerM.KosF.GannonHuman estrogen receptor-alpha: regulation by synthesis, modification and degradationCell Mol Life Sci5952002821831
   PubMed Web of Science ®Google Scholar
• G.FlouriotH.BrandS.DengerR.MetivierM.KosG.ReidIdentification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1EMBO J1917200046884700
   Web of Science ®Google Scholar
• L.LiM.P.HaynesJ.R.BenderPlasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cellsProc Natl Acad Sci USA1008200348074812
   PubMed Web of Science ®Google Scholar
• K.H.KimJ.R.BenderRapid estrogen receptor-mediated signaling: why is the endothelium so special?Sci STKE2882005Pe28
   Google Scholar
• Z.WangX.ZhangP.ShenB.W.LoggieY.ChangT.F.DeuelIdentification, cloning, expression of human estrogen receptor alpha36, a novel variant of human estrogen receptor-alpha66Biochem Biophys Res Commun3364200510231027
   PubMed Web of Science ®Google Scholar
• P.AscenziA.BocediM.MarinoStructure–function relationship of estrogen receptor alpha and beta: impact on human healthMol Aspects Med2742006299402
   Google Scholar
• J.W.ParkR.M.NeveJ.SzollosiC.C.BenzUnraveling the biologic and clinical complexities of HER2Clin Breast Cancer852008392401
   Web of Science ®Google Scholar
• C.C.BenzG.K.ScottJ.C.SarupR.M.JohnsonD.TripathyE.CoronadoEstrogen-dependent tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neuBreast Cancer Res Treat24219928595
   Web of Science ®Google Scholar
• M.C.GutierrezS.DetreS.JohnstonS.K.MohsinJ.ShouD.C.AllredMolecular changes in tamoxifen resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinaseJ Clin Oncol2311200524692476
   PubMed Web of Science ®Google Scholar
• L.CoussensT.L.Yang-FengY.C.LiaoE.ChenA.GrayJ.McGrathTyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with NEU oncogeneScience2304730198511321139
   PubMed Web of Science ®Google Scholar
• M.A.MolinaR.SáezE.E.RamseyM.J.Garcia-BarchinoF.RojoA.J.EvansNH (2)-terminal truncated HER-2 protein but not full-length receptor is associated with nodal metastasis in human breast cancerClin Cancer Res822002347353
   Web of Science ®Google Scholar
• G.K.ScottR.RoblesJ.W.ParkP.A.MontgomeryJ.DanielW.E.HolmesA truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cellsMol Cell Biol134199322472257
   PubMed Web of Science ®Google Scholar
• M.A.OwensB.C.HortenM.M.Da SilvaHER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissuesClin Breast Cancer5120046369
   PubMedGoogle Scholar
• D.J.SlamonW.GodolphinL.A.JonesJ.A.HoltS.G.WongD.E.KeithStudies of the HER-2/neu protooncogene in human breast and ovarian cancerScience24449051989707712
   PubMed Web of Science ®Google Scholar
• E.El-AbdA.HassanW.FaiedS.ZakiA.SobhiS.El-SwedyClinical relevance of HIF-1 alpha, Cox-2, leptin, and prolactin as hypoxic markers in breast cancerAJC1142012237246
   Google Scholar
• The Belmont Report. Ethical Principles and Guidelines for the Protection of Human Subjects of Research. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. April 18, 1979. http://www.hhs.gov/ohrp/policy/belmont.html (accessed 28.01.14).
   Google Scholar
• S.E.SingletaryJ.L.ConnollyBreast cancer staging: working with the sixth edition of the AJCC Cancer Staging ManualCA Cancer J Clin5620063747
   PubMed Web of Science ®Google Scholar
• A.SaadM.ShetaA.SobhiE.AlyE.El-AbdClinical and pathological assessment of sentinel lymph node micrometastasis in breast cancer using RT-PCRJ Egypt Soc Path25120058187
   Google Scholar
• N.Abd EL-MoneimS.EbidA.KazemA.SaadS.MousaE.EL-ABDThe role of angiogenesis assessment in the prognosis of breast carcinoma and in the evaluation of the therapeutic effect of “shark care” drug as an angiogenesis inhibitorTurkish J cancer3832008123134
   Google Scholar
• M.NadjiQuantitative Immunohistochemistry of estrogen receptor in breast cancer. “much ado about nothing!”Appl Immunohistochem Mol Morphol1622008105107
   Google Scholar
• D.C.AllredJ.M.HarveyM.BerardoG.M.ClarkPrognostic and predictive factors in breast cancer by immunohistochemical analysisMod Pathol1121998155168
   PubMed Web of Science ®Google Scholar
• L.J.LayfieldD.GuptaE.E.MooneyAssessment of tissue estrogen and progesterone receptor levelsBreast J632000189196
   Google Scholar
• A.RhodesB.JasaniD.M.BarnesL.G.BobrowK.D.MillerReliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systemsJ Clin Pathol5322000125130
   PubMed Web of Science ®Google Scholar
• A.M.GownCurrent issues in ER and HER2 testing by IHC in breast cancerMod Pathol21Suppl 22008S8S15
   PubMed Web of Science ®Google Scholar
• T.OyamaY.IshikawaM.HayashiK.ArihiroJ.HoriguchiThe effects of fixation, processing and evaluation criteria on immunohistochemical detection of hormone receptors in breast cancerBreast cancer1422007182188
   Google Scholar
• A.L.WijayaratneD.P.McDonnellThe human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulatorsJ Biol Chem2763820013568435692
   PubMed Web of Science ®Google Scholar
• R.L.EckertA.MullickE.A.RorkeB.S.KatzenellenbogenEstrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift techniqueEndocrinology11421984629637
   Web of Science ®Google Scholar
• F.J.MonsmaJrB.S.KatzenellenbogenM.A.MillerY.S.ZieglerJ.A.KatzenellenbogenCharacterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogenEndocrinology11511984143153
   Web of Science ®Google Scholar
• S.SchollM.E.LippmanThe estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptorEndocrinology1154198412951301
   Web of Science ®Google Scholar
• S.DauvoisP.S.DanielianR.WhiteM.G.ParkerAntiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnoverProc Natl Acad Sci USA899199240374041
   PubMed Web of Science ®Google Scholar
• J.VarayoudJ.G.RamosL.MonjeV.BosquiazzoM.Muñoz-de-ToroE.H.LuqueThe estrogen receptor UTR3 mRNA splicing variant is differentially regulated by estrogen and progesterone in the rat uterusJ Endocrinol186120055160
   Web of Science ®Google Scholar
• T.A.HoppS.A.FuquaEstrogen receptor variantsJ Mammary Gland Biol Neoplasia3119987383
   PubMed Web of Science ®Google Scholar
• R.L.BalleineS.M.HuntC.L.ClarkeCoexpression of alternatively spliced estrogen and progesterone receptor transcripts in human breast cancerJ Clin Endocr Metab844199913701377
   Web of Science ®Google Scholar
• E.R.LeygueP.H.WatsonL.C.MurphyEstrogen receptor variants in normal human mammary tissueJ Natl Cancer Inst8851996284290
   Google Scholar
• P.GallacchiF.SchoumacherS.Eppenberger-CastoriE.M.Von LandenbergW.KuengU.EppenbergerIncreased expression of estrogen receptor exon-5-deletion variant in relapse tissues of human breast cancerInt J Cancer79119984448
   Web of Science ®Google Scholar
• A.A.DaffadaS.R.JohnstonI.E.SmithS.DetreN.KingM.DowsettExon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancerCancer Res5521995288293
   Web of Science ®Google Scholar
• S.G.KoehorstJ.J.CoxG.H.DonkerS.Lopes da SilvaJ.P.BurbachJ.H.ThijssenFunctional analysis of an alternatively spliced estrogen receptor lacking exon 4 isolated from MCF-7 breast cancer cells and meningioma tissueMol Cell Endocrinol1011-21994237245
   Web of Science ®Google Scholar
• H.JiangR.TengQ.WangX.ZhangH.WangZ.WangTranscriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissuesJ Steroid Biochem Mol Biol1121–320082024
   Web of Science ®Google Scholar
• M.A.RunnakM.A.HazhaH.A.HeminA.A.WasanR.M.RekawtH.D.MichaelA population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER dataBMC Womens Health12201216
   Web of Science ®Google Scholar
• Ismail MF, Aly MS, Khaled HM, Mohamed HM. Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer. Ger, Med Sci 2009;7:Doc03.
   Google Scholar
• K.A.CroninL.C.HarlanK.W.DoddJ.S.AbramsR.Ballard-BarbashPopulation-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the USCancer Invest2892010963968
   PubMed Web of Science ®Google Scholar
• J.S.RossJ.A.FletcherG.P.LinetteJ.StecE.ClarkM.AyersThe Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapyOncologist842003307325
   PubMed Web of Science ®Google Scholar
• R.E.EllsworthD.L.EllsworthH.L.PatneyB.DeyarminB.LoveJ.A.HookeAmplification of HER2 is a marker for global genomic instabilityBMC Cancer82008297
   PubMed Web of Science ®Google Scholar